DUBLIN, Jan. 7, 2022 /PRNewswire/ — The "U.S. Biopharmaceutical Third Party Logistics Market Size, Share & Trends Analysis Report by Product Type (Specialty Drugs, Generics), by Supply Chain (Non-cold, Cold Chain), by Service Type, and Segment Forecasts, 2021 – 2028" report has been added to ResearchAndMarkets.com’s offering. Research and Markets Logo The U.S. biopharmaceutical third party logistics market size is expected to reach USD 62.3 billion by 2028, at a CAGR 7.1%

Increasing demand for novel biologics and the need to manage those is boosting the market growth. Moreover, the rising demand for temperature-controlled logistic services to transport biologics in […]

See also  SmartMetric, the Developer of the Biometric Secured Credit Card, Says the Continued Blow Out in the Cost of Fraud for United States Merchants, Now Estimated at More Than $39 Billion, Is Unsustainable

By Donato